Eric Branderiz Buys 8,334 Shares of Quantinuum (NASDAQ:QNT) Stock

Quantinuum Inc. (NASDAQ:QNTGet Free Report) Director Eric Branderiz acquired 8,334 shares of Quantinuum stock in a transaction on Friday, June 5th. The shares were bought at an average cost of $60.00 per share, with a total value of $500,040.00. Following the completion of the purchase, the director owned 14,167 shares in the company, valued at $850,020. The trade was a 142.88% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Quantinuum Trading Down 5.9%

QNT opened at $54.94 on Wednesday. Quantinuum Inc. has a 52 week low of $51.15 and a 52 week high of $71.35.

Key Stories Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

  • Positive Sentiment: Multiple Quantinuum directors and executives, including Hal Barron, bought shares at $60 apiece, with Barron’s 250,000-share purchase standing out as a major vote of confidence from leadership. SEC filing for Hal Barron purchase
  • Positive Sentiment: Other insiders also added to their holdings, including Joseph Jimenez, Manish H. Bhatia, Kenneth D. Denman, Kevin Scott Dehoff, and Nitesh Sharan, reinforcing the bullish signal from inside the company. SEC filing for Joseph Jimenez purchase
  • Positive Sentiment: Director Prineha Narang also bought shares, adding to the insider-buying trend and helping support investor sentiment around QNT. Insider trades article on Prineha Narang purchase
  • Neutral Sentiment: A recent commentary piece, “Quantinuum: Buying Apollo Today,” appears generally constructive, but it does not introduce a clear new fundamental catalyst. Seeking Alpha article
  • Neutral Sentiment: Broader quantum-computing coverage also shows investor capital still flowing into the sector, with IQM raising fresh funding ahead of its debut, which may help keep attention on QNT’s market category. Barrons article on quantum-computing capital
  • Negative Sentiment: Jim Cramer’s criticism that Quantinuum is “a very unprofitable venture right now” may temper enthusiasm by reminding investors that profitability remains a concern. Insider Monkey article on Jim Cramer comments

See Also

Insider Buying and Selling by Quarter for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.